Beijing News reported on October 29 that Medlander released its Q3 2024 report. In the first three quarters of this year, the company achieved operating revenue of 331 million yuan, a year-on-year increase of 13.81%; net profit attributable to shareholders reached 96.0706 million yuan, a year-on-year increase of 13.37%.
In Q3, the company achieved revenue of 102 million yuan, a year-on-year increase of 18.75%; net profit attributable to shareholders was 23.4639 million yuan, a year-on-year decrease of 9.39%.
Data shows that Medlander was established in 2013 and is a provider of physical rehabilitation intervention technology solutions for women's entire life cycle in China. The company is mainly engaged in the research and development, production, sales, and service of related products.
Proofread by Mu Xiangtong

